Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
They also had lower serum vitamin D levels (56.68 vs. 60.12 nmol/L, p = 0.022) and consumed less alcohol (59.66% vs. 71.19%, p < 0.001) (Table 1).
Source: Baseline demographic and clinical characteristics. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cross-sectional study.
Cross-sectional study
Examines a population at a particular point in time.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
This cross-sectional study analyzed data from the National Health and Nutrition Examination Survey (NHANES) collected between 2011 and 2018, including 3,391 participants aged 20 to 59 years.
Source: Methods.
This cross-sectional study analyzed data from the National Health and Nutrition Examination Survey (NHANES) collected between 2011 and 2018, including 3,391 participants aged 20 to 59 years.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Exposure to volatile organic compounds and sarcopenia risk in US adults based on NHANES
Cross-sectional study · Scientific Reports · 2025
Original publication title
Exposure to volatile organic compounds and sarcopenia risk in US adults based on NHANES
© The Author(s) 2025
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
This study investigates the association between volatile organic compounds (VOCs) and sarcopenia in a cohort of 3,391 U.S. participants aged 20 to 59 years, using NHANES data from 2011 to 2018. Various urinary metabolites of VOCs (mVOCs) were analyzed, and in multivariate logistic regression, CEMA (a metabolite of acrolein), CYMA (a metabolite of acrylonitrile), ATCA (a metabolite of cyanide), and 3,4-MHA (a metabolite of xylene) were found to have significant associations with sarcopenia. Weighted Quantile Sum (WQS) and Bayesian Kernel Machine Regression (BKMR) analyses further supported these findings, identifying ATCA as a key contributor.
Subgroup analyses revealed meaningful associations between sarcopenia and mVOCs in both men and women. Additionally, mediation analysis identified high-density lipoprotein (HDL) as a partial mediator, contributing to 3.8% of the effect. These results emphasize the need for future longitudinal studies to establish causality and further explore the underlying biological mechanisms.
Supplementary Information
The online version contains supplementary material available at 10.1038/s41598-025-11628-0.
Authors’ abstract
This study investigates the association between volatile organic compounds (VOCs) and sarcopenia in a cohort of 3,391 U.S. participants aged 20 to 59 years, using NHANES data from 2011 to 2018. Various urinary metabolites of VOCs (mVOCs) were analyzed, and in multivariate logistic regression, CEMA (a metabolite of acrolein), CYMA (a metabolite of acrylonitrile), ATCA (a metabolite of cyanide), and 3,4-MHA (a metabolite of xylene) were found to have significant associations with sarcopenia. Weighted Quantile Sum (WQS) and Bayesian Kernel Machine Regression (BKMR) analyses further supported these findings, identifying ATCA as a key contributor.
Subgroup analyses revealed meaningful associations between sarcopenia and mVOCs in both men and women. Additionally, mediation analysis identified high-density lipoprotein (HDL) as a partial mediator, contributing to 3.8% of the effect. These results emphasize the need for future longitudinal studies to establish causality and further explore the underlying biological mechanisms.
Supplementary Information
The online version contains supplementary material available at 10.1038/s41598-025-11628-0.
Publication and source details
Original title: Exposure to volatile organic compounds and sarcopenia risk in US adults based on NHANES
Tian-Zhen Qu; Yue Zhang; Qing-Yun Huang; Xing-Lan Chen; Ye Zhu
Scientific Reports · 2025
© The Author(s) 20252025https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T04:02:09.527757+00:00
DOI: 10.1038/s41598-025-11628-0 · PMC12264073